4.3 Article

Amylin antibodies frequently display cross-reactivity with CGRP: characterization of eight amylin antibodies

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpregu.00338.2020

关键词

amylin; antibody; CGRP; cross-reactivity; pancreas

资金

  1. Marsden Fund (Royal Society of New Zealand)
  2. Royal Society of New Zealand
  3. Health Research Council (New Zealand)
  4. University of Auckland

向作者/读者索取更多资源

This study found that current amylin antibodies frequently cross-react with CGRP, making them unsuitable for use in tissues that highly express CGRP. Therefore, previous studies using these antibodies should be reevaluated in light of these findings.
Amylin is a 37-amino acid endocrine hormone secreted from the pancreas in response to nutrient intake, acting centrally to promote meal-ending satiation. With many studies linking amylin action to the nervous system, determining the distribution or expression of amylin in the nervous system is critical. However, amylin shares sequence identity and structural homology to the related neuropeptide calcitonin gene-related peptide (CGRP). This creates challenges in identifying selective amylin antibodies that do not cross-react with CGRP, especially in neural tissues, where CGRP is densely packed into secretory vesicles. Here, we characterized eight amylin antibodies to determine their ability to detect amylin and cross-react with rat or human alpha CGRP, using immunoblots and preabsorption controls in rat pancreas. We observed that amylin antibodies frequently cross-reacted with alpha CGRP and are therefore not suitable for use in tissues that highly express CGRP. Earlier work using these antibodies should be revisited in light of our findings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据